Pharmacokinetics and pharmacodynamics of dasatinib in the chronic phase of newly diagnosed chronic myeloid leukemia.
Ishida Y, Murai K, Yamaguchi K, Miyagishima T, Shindo M, Ogawa K, Nagashima T, Sato S, Watanabe R, Yamamoto S, Hirose T, Saitou S, Yonezumi M, Kondo T, Kato Y, Mochizuki N, Ohno K, Kishino S, Kubo K, Oyake T, Ito S; Inter-Michinoku Dasatinib Study Group (IMIDAS).
Ishida Y, et al. Among authors: oyake t.
Eur J Clin Pharmacol. 2016 Feb;72(2):185-93. doi: 10.1007/s00228-015-1968-y. Epub 2015 Oct 27.
Eur J Clin Pharmacol. 2016.
PMID: 26507546
Clinical Trial.